Role of H2 receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial

doi:10.12998/wjcc.v10.i23.8170

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4270)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

313

WORD

HTML

2001

Figures (1-3)

351

Tables (1-6)

242

Sum=2977

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

337

Download

956

Sum=1293

Aug 16, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Aug 16, 2022; 10(23): 8170-8185
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8170

Full Size Figure Download Figure

Figure 2 Kaplan Meier survival analysis among the study groups showing no significant survival benefit in favor of famotidine as added treatment against the control group, P > 0. 05.

Citation: Mohiuddin Chowdhury ATM, Kamal A, Abbas MKU, Karim MR, Ali MA, Talukder S, Hamidullah Mehedi HM, Hassan H, Shahin AH, Li Y, He S. Role of H₂receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial. World J Clin Cases 2022; 10(23): 8170-8185
URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8170.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8170